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Mesenchymal stem cells (MSCs) are a source of adult multipotent cells important in tissue regeneration. Murine MSCs are known
to proliferate poorly in vitro under normoxia.The aim of this study is to analyze the interaction of nonphysiological high oxygen and
low-dose 𝛾-irradiation onto growth, senescence, and DNA damage. Tri-potent bone marrow-derivedMSCs from p53 wildtype and
p53−/−mice were cultured under either 21% or 2%O
2
. Long-term observations revealed a decreasing ability of wildtypemMSCs to
proliferate and form colonies under extended culture in normoxia.This was accompanied by increased senescence under normoxia
but not associated with telomere shortening. After low-dose 𝛾-irradiation, the normoxic wildtype cells further increased the level
of senescence. The number of radiation-induced 𝛾H2AX DNA repair foci was higher in mMSCs kept under normoxia but not in
p53−/− cells. P53-deficient MSCs additionally showed higher clonogeneity, lower senescence levels, and fewer 𝛾H2AX repair foci
per cell as compared to their p53 wildtype counterparts irrespective of oxygen levels.These results reveal that oxygen levels together
with 𝛾-irradiation and p53 status are interconnected factors modulating growth capacity of BMMSCs in long-term culture. These
efforts help to better understand and optimize handling of MSCs prior to their therapeutic use.
1. Introduction
Mesenchymal stem cells (MSCs) are multipotent with a
life-long proliferation capacity in the adult organism. Their
potential to generate precursors for osteoblasts, adipocytes,
fibroblasts, and chondroblasts in vitro [1, 2] has prompted
the idea that they could also be a reservoir for the regen-
eration of connective tissue after injuries and fractures or
during normal cell loss [3]. Because of their multilineage
differentiation capacity and long-termproliferation potential,
they have received interest as vehicles for the treatment
of chronic degenerative diseases and acute tissue injuries
[4]. The relative ease of harvesting facilitates autologous
transplantation of MSCs into a diseased target organ, usually
after the cells have been expanded ex vivo [5]. Some of
their therapeutic benefits are also found to be conferred by
anti-inflammatory and immunomodulatory factors secreted
by the transplanted MSCs, rather than by the generation
of viable cell progeny [6]. This may explain their reported
efficiency as supplements in wound healing [7], bonemarrow
transplantation (to reduce graft-versus-host disease, GvHD)
[8], and cardiac surgery [9].
At the time of writing, 529 clinical trials using MSCs are
registered worldwide (https://www.clinicaltrials.gov/), with
the majority intended to treat disorders of the CNS (12%),
cardiac disease (10%), various types of autoimmune diseases
(9%), joint and skeletal diseases (8%), metabolic disorders
(7%), and GvHD (6%). Although the therapeutic procedures
of autologous MSC transplantation are considered safe and
more robust than allogenic transplantation protocols, the
success of treatment in individual patients is variable [10]. To
what extent transplanted MSCs proliferate and whether they
are able to differentiate into fully functional cells capable of
regenerating damaged tissue are usually not determined [11].
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The mechanisms by which genetic, epigenetic, or environ-
mental factors govern the efficiency of an MSC therapy are
difficult to assess directly in patients but can be systematically
studied in model organisms such as guinea pig, mice [12, 13],
or minipig [14].
We are interested in the influence of genotoxic stress
acting on MSCs both prior to and during ex vivo expansion,
in particular by non-physiologically high oxygen levels and
by ionizing radiation (IR). The sensitivity of eukaryotic cells
to IR-induced cell killing depends on the presence of oxygen
[15]. In vitro studies of cancer cell lines show that hypoxia
confers radioresistance, which is associated with a lower level
of DNA lesions in the nucleus [16]. MSCs in their normal
physiological context reside in hypoxic niches [17, 18] and
might therefore be relatively protected from radical oxygen
species (ROS), which are generated by ionizing radiation.
In the case of haematopoietic stem cells derived from bone
marrow, exposure to atmospheric oxygen has been shown
to trigger EPHOSS (for extraphysiologic oxygen shock or
stress) that is linked to activation of the p53 pathway and
mitochondria-mediated apoptosis [19]. Although our own
studies indicate that apoptosis is, unlike in haematopoietic
cells, not a common mechanism in MSCs during aging
or after cytogenetic stress, a p53-mediated DNA damage
response (DDR) could also impair their stem cell potency by
premature senescence or differentiation. Since murine MSCs
growing in vitro depend on a hypoxic environment [20], they
are a suitable model to investigate the mechanisms of oxygen
induced cellular stress both alone and also in combination
with a low-dose radiation exposure.
We have examined the growth capacity, clonogenic
potential, senescence induction, accumulation of DNA dam-
age, and rate of telomere attrition of mMSCs grown under
two different oxygen concentrations. Since the first findings
suggested senescence induction and involvement of accumu-
latingDNAdamage, we tested this assumption by low-dose 𝛾-
irradiation of mMSCs comparing p53 wild-type with p53−/−
cells.
2. Materials and Methods
2.1. Cultivation of Primary Murine MSCs. Female FVB/N
p53wt/wt andC57BL/6 p53−/−mice, 3 to 12months old, were
originally supplied by Charles River Laboratories (Sulzbach,
Germany) and maintained in a breeding colony at the
Helmholtz Center Munich under specific pathogen-free con-
ditions. To collect bone marrow MSCs, mice were sacrificed
by CO
2
exposure, the hind limbs were aseptically dissected,
and the femurs were cleaned from adherent tissues. One
tip of each femur was removed and the bone marrow was
collected by flushing with ice-cold PBS. After disaggregating
larger clumps of bone marrow and allowing remaining cell
clumps to sediment, the supernatant was centrifuged (5min
at 300×g), and the resulting cell pellet was washed again with
PBS. Finally, bone marrow cells were plated at a cell density
of 5,000,000 per 6-well plate inDMEM/F12media containing
10%mesenchymal stem cell qualified FBS (Life Technologies,
Carlsbad, CA). The cultures were kept in a humidified
5% CO
2
incubator at 37∘C under 21% (normoxia) or 2%
(hypoxia)O
2
. After 4 h, 6 h, and twice a day for the following 3
days, supernatant containing nonadherent cells was aspirated
and fresh complete medium was added. Adhering cells were
grown for 7 days, detached for passaging with the StemPro
Accutase Cell Dissociation Reagent (Life Technologies), and
cell numberswere obtainedusing aCoulterCounterAnalyzer
(Beckman Coulter, Brea, CA). Growth medium was changed
every 3.5 days and cells were passaged once a week.
2.2. In Vitro Induction of Lineage Differentiation. To verify
the multilineage differentiation potential (Supplementary
Figure 1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/6429853) the isolated mMSCs
were plated at densities of 3,000 (osteogenic), 10,000 (adi-
pogenic), or 80,000 (chondrogenic) cells per well in 96-
well culture plates. For chondrogenic differentiation, cells
were allowed to attach for 2 h before inducing the differen-
tiation, using chondrogenic differentiation medium. In the
case of osteogenic and adipogenic differentiation the cells
were stimulated with appropriate differentiation medium
only after 2 to 3 days. Remaining wells served as controls
using normalMSC growthmedium.All differentiation assays
were performed under hypoxic conditions. Following lineage
induction, cultures were stained and visualized on a Keyence
BZ9000 microscope (Keyence, Neu-Isenburg, Germany).
2.2.1. Alkaline Phosphatase Staining of Osteogenic Differ-
entiation. Murine MSCs were stimulated for up to 2
weeks in StemPro osteocyte/chondrocyte differentiation
basal medium supplemented with StemPro Osteogenesis
Supplement (Life Technologies). After fixation of the cells
with 4% paraformaldehyde, alkaline phosphatase activity
was revealed by SigmaFast BCIP/NBT chromogen staining
(Sigma Aldrich, St. Louis, MO) according to PromoCell’s
application note for “osteoblast differentiation and mineral-
ization” (PromoCell GmbH, Heidelberg, Germany).
2.2.2. Oil Red O Staining for Adipogenic Differentiation.
Murine MSCs were stimulated for 2 weeks in StemPro
Adipocyte differentiation basal medium supplemented with
StemProAdipogenesis Supplement (Life Technologies). After
fixation of the cells with 4% paraformaldehyde, lipid vacuoles
were stained for 45min at room temperature with an Oil red
O buffer solution (60% isopropanol with 3mg/mL Oil red O
(Sigma Aldrich), 40% H
2
O) and rinsed with water.
2.2.3. Alcian Blue Staining for Chondrogenic Differentia-
tion. Murine MSCs were stimulated for 3 weeks in Stem-
Pro Osteocyte/Chondrocyte differentiation basal medium
supplemented with StemPro Chondrogenesis Supplement
(Life Technologies). After fixation of the cells with 4%
paraformaldehyde, proteoglycan aggrecan in the cartilage
extracellular matrix was stained by an Alcian Blue 8GX
dye (Sigma Aldrich) according to PromoCell’s application
note for “chondrogenic differentiation and analysis of MSC”
(PromoCell).
2.3. Clonogenic Survival. For the measurement of clonogenic
survival, between 500 and 5,000 mMSCs per 75 cm2 were
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seeded in cell culture flasks under either normoxia or
hypoxia. After 10 to 14 days, the colony formation capacity
was assayed after ethanol fixation andGiemsa (Merck, Darm-
stadt, Germany) staining. Plating efficiency in percentage was
calculated by the following formula: (number of colonies
formed/number of seeded cells) × 100.
2.4. Irradiation. Irradiation of mMSCs was performed with
a Cs-137 irradiator (HWM D-2000, Siemens, Germany) at
a dose rate of 0.5 Gy/min. For irradiation doses lower than
0.5Gy, a shielded lead box was used with an attenuation
factor of 10%. Doses were administered at room temperature
and control cells were sham-irradiated. During the entire
irradiation procedure (about 20min) the cell culture vessels
were sealed with parafilm to reduce gas exchange.
2.5. Senescence Analysis. For assessment of senescence asso-
ciated 𝛽-galactosidase activity 7 days after irradiation, sub-
confluent mMSCs in 96-well culture plates were washed
with PBS, fixed with 4% paraformaldehyde, again washed


















O, and 1mg/mL X-
gal, pH 6). Multicolored microscope images were taken with
a Keyence BZ9000 microscope.
2.6. Analysis of p53 Stabilization and 𝛾H2AX DNA Damage
Repair Foci. Murine MSCs were seeded on glass slides and
grown in either hypoxia or normoxia for at least 24 h.
Following irradiation, the cells were fixed at the indicated
time points (methanol for p53 or 4% paraformaldehyde
for 𝛾H2AX). Fixed cells were washed in PBS, treated with
0.05% Saponin (40min for p53) or 0.2% Triton-X (5min for
𝛾H2AX) in PBS, washed in PBS, and blocked with 10mg/mL
BSA and 1.5mg/mL glycine in PBS for 1 h at room temper-
ature. Cells were incubated with primary antibodies against
phosphorylated 𝛾H2AX (Upstate Biotechnology, Lake Placid,
NY) diluted in antibody dilution solution (DCS, Hamburg,
Germany) or against p53 (R19, Santa Cruz Biotechnology,
Dallas, TX) in PBS for at least 90min. For visualization
goat anti-mouse Cy3-conjugated secondary antibody (GE
Healthcare GmbH, Freiburg, Germany) diluted in anti-
body dilution solution or HRP-conjugated donkey anti-goat
secondary antibody (Santa Cruz Biotechnology) was used
after washing slides in PBS (and blocking peroxidases for




for p53). For immunohistochemical
staining of p53, SIGMAFAST DAB (3,3󸀠-diaminobenzidine
tetra hydrochloride, Sigma Aldrich) was added overnight.
After a final PBS washing step slides were mounted in DAPI-
containing mounting medium and analyzed with a Keyence
BZ9000 microscope. The Keyence software counted nuclear
foci in at least 50 cells. Appropriate negative controls were
obtained by staining a replicate slide with the secondary
antibody only.
2.7. Telomere Length Determination. Quantitative PCR of
genomic DNA extracted from mMSCs was done to mea-
sure telomeric length [21]. For this purpose, qRT-PCR was
set up using (TTAGGG)n primers detecting the telomere
sequence and primers for a genomic microsatellite marker
(D14Mit192) for genomicDNAnormalization in two separate
reactions. Quantitative real-time amplification was done on a
StepOne+ device (Life Technologies), using the “Power Sybr-
Green” master mix (including Rox-standard), 2 pmol of each
primer, and 10 ng genomic DNA in a 20 𝜇L reaction volume.
Relative telomeric length was calculated by the delta-delta
CT method, with pooled newborn mouse skin DNA as a
calibrator (set as 100 arbitrary units, AU).
2.8. Triplex Assay to Quantify Viability, Cytotoxicity, and
Apoptosis Induction. Murine MSCs were seeded on 96-
well plates, irradiated, and incubated in either hypoxia or
normoxia for 7 days. Viability, cytotoxicity, and apoptosis
were assessed in one well using the ApoTox-Glo Triplex assay
(Promega, Madison, WI). In a first step, the cell-permeable
substrate glycylphenylalanyl-aminofluoro-coumarin (GF-
AFC) is cleaved by live-cell protease activity to generate
a fluorescent signal (400 nm excitation, 505 nm emission)
proportional to the number of living cells. In parallel the
nonpermeable substrate bis-alanylalanyl-phenylalanyl-
rhodamine 110 (bis-AAF-R110; 485 nm excitation, 520 nm
emission) is used to measure dead-cell protease activity,
which is released from cells that have lost membrane
integrity. In a second step, the addition of CaspaseGlo 3/7
reagent results in cell lysis, followed by caspase cleavage
of the substrate and generation of luminescent signal
produced by luciferase. Both fluorescence and luminescence
signals were analyzed in a microplate reader (Infinite
200, Tecan, Männedorf, Switzerland). Positive controls for
necrosis had cells exposed for 6 h to 100 𝜇M ionomycin, and
positive controls for apoptosis had cells exposed to 100 𝜇M
staurosporine for 6 h (both Sigma Aldrich), incubated under
hypoxia.
2.9. Statistical Analysis. All experiments were performed
with at least duplicate technical and biological replicates.
Mean ± standard errors of the mean (SEM) values are
depicted unless stated otherwise. Results were statistically
evaluated with indicated tests by the statistic software
SigmaPlot (Systat Software Inc., San Jose, CA) and SPSS
version 22 (IBM Corp, Armonk, NY). Statistical significance
was accepted at the 𝑝 < 0.05 level.
3. Results
3.1. Oxygen Concentration Affects Long-Term In Vitro Pro-
liferative Potential of Murine MSCs. In line with previously
published studies [22], we observed increased proliferation
of mMSCs in a 2%O
2
(hypoxic) environment as compared to
the 21% O
2
(normoxic) environment. As the time in culture
progressed, the total cell numbers in hypoxic cultures were
significantly higher as compared to those in normoxic culture
conditions. Representative images show long-term cultured
hypoxic and normoxic mMSCs on day 32 after isolation
(Figure 1(a)).
3.2. Normoxic Culture Condition Reduces Colony Forming
Ability of mMSCs. The reduced cellularity of normoxia
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Figure 1: Effects of oxygen levels on long-term in vitro culturing and colony forming capacity of p53 wild-type mMSCs. (a) Proliferation and
morphology of mMSCs p53wt/wt cultured in hypoxic conditions (2% O
2
, left) and in normoxic conditions (21% O
2
, right). Representative
images show mMSCs cultured for 32 days. (b) Colony forming ability of mMSCs in hypoxic (upper) and normoxic (lower) atmospheres 14
days after plating 5,000 cells in a 75 cm2 flask. (c) Plating efficiency calculated as mean values of fibroblast colony forming units (CFU-F) per
plated cell ± standard error of the mean (𝑛 = 4) in hypoxic (grey bar) and normoxic (black bar) conditions.
grown mMSC cultures was due to a reduced ability to
form colonies. Thus, clonogenic assays of mMSCs revealed
a tenfold higher number of colonies (2.04%) under hypoxia,
as compared to growth under normal oxygen conditions
(0.21%) (Figures 1(b) and 1(c)) (𝑝 = 0.03, one-tailed paired
Student’s 𝑡-test). These results prove that the clonogenicity of
mMSCs is impaired in normoxic cultures.
3.3. Normoxia Increases the Sensitivity of mMSCs towards
Radiation-Induced Senescence. We have not seen a relevant
increase of necrotic or apoptotic cells using a multiplex
assay with fluorescent GF-AFC/bis-AAF-R100 and lumi-
nescent caspase-3/-7 substrates (Supplementary Figure 2),
neither after irradiation nor by normoxia. So we hypoth-
esized that senescence is the key mechanism of decreased
proliferative and loss of colony forming ability of mMSCs
in cultures with ambient oxygen concentration (21% O
2
).
To investigate the possible role of oxygen on senescence
induction, subconfluent mMSC cultures under hypoxic and
normoxic conditions were stained for senescence-associated
𝛽-galactosidase (SA 𝛽-gal) activity. In sham-irradiated cells
that were transferred to normoxic conditions, we observed a
strong increase to 54 ± 1.2% senescent cells, as compared to
31±2.8% in cells kept under hypoxic conditions for the same
time (Figure 2(a)).
Ionizing radiation (IR) is known to generate oxidative
stress in cells [23].Therefore, we exposedmMSCsmaintained
in hypoxic and normoxic conditions to increasing doses of
𝛾-irradiation (0.1 Gy, 0.2Gy, 0.5 Gy, and 4Gy). Cells irradi-
ated with a dose as high as 4Gy exhibited a change in the
MSCs’ typical spindle cell morphology, which might indicate
cellular stress. There was also a much reduced cell growth
of MSCs following 4Gy irradiation, as measured by lower
cell numbers after 7 days under both oxygen concentrations
(Figure 2(a)). The combination of higher oxygen and IR
significantly increased senescence in mMSCs (𝑝 = 0.003,
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Figure 2: Effects of oxygen levels on sensitivity of p53 wild-type mMSCs for radiation-induced senescence. (a) Green SA 𝛽-gal positive
mMSCs in sham-irradiated (0Gy) hypoxic (upper left) and in normoxic cultures (upper right) and 7 days after exposure to 4Gy 𝛾-irradiation
(hypoxia, lower left, and normoxia, lower right). (b) Percentage of cells undergoing senescence in hypoxic and normoxic conditions after
increasing doses of 𝛾-irradiation depicted as mean values ± standard error of themean (4 biological replicates), radiation dose on logarithmic
scale.
ANOVA). Irradiation could independently cause mMSCs to
undergo senescence (𝑝 = 0.031, ANOVA). Ambient oxygen
concentration was also found to be a crucial factor respon-
sible for increasing senescence in mMSCs (𝑝 = 3.2 × 10−18,
ANOVA). All together this suggests that normoxia increases
the sensitivity of mMSCs towards radiation-induced senes-
cence.
3.4. Murine MSCs Grown in Normoxia Have Higher Basal
Levels of DNA Damage and Show a Greater Increase after 𝛾-
Irradiation. In sham-irradiatedmMSCsunder hypoxia,most
of the cells showed an absence of 𝛾H2AX foci, with a mean
value of 0.5 (range from 0 to 2) foci per nucleus (Figures
3(a) and 3(b)). The number and the size of the 𝛾H2AX foci
were significantly increased when cells were grown under









































Figure 3: Effects of oxygen levels on the number of repair foci in sham-irradiated and 4Gy irradiated p53wt/wt mMSCs. (a) Sham-irradiated
(0Gy) 𝛾H2AX foci formation under normoxic cultures (right upper image) and hypoxic cultures (left upper image) and additionally 90min
after exposure to 4Gy 𝛾-irradiation (lower images). (b) Quantification of 𝛾H2AX foci in 50 p53wt/wtmMSCnuclei depicted asmean values ±
standard error of the mean (3 biological replicates).






























Figure 4: Effects of oxygen levels on telomeric length. Graph
shows quantitative genomic PCR telomeric length determination
performed with p53wt/wt mMSCs under hypoxic and normoxic
conditions and with a pool of newborn mouse skin DNA as
calibrator (set to 100 arbitrary units, AU). Fitted lines are exponential
regression curves, and the differences are not significant.
normoxic conditions, reaching mean values of 4.0 (range
from 2 to 6) foci per cell.
4 Gy irradiated mMSCs cultured under hypoxia
increased the number of foci per cell to a mean value of 2.3
(range from 0 to 4) foci per nucleus (Figures 3(a) and 3(b)),
indicating ongoing repair. 4 Gy irradiated mMSCs cultured
under normoxia showed massive appearance of 𝛾H2AX foci
with a mean value of 7.5 per nucleus (range from 4 to more
than 20 foci in some cells). These experiments indicate that
normoxia increases the sensitivity of mMSCs towards DNA
lesions when 𝛾-irradiation is applied.
3.5. No Effect of Normoxia on mMSC Telomere Shortening.
DNA damage signaling can also be triggered by dysfunc-
tional, eroding telomeres [24].Therefore the relative telomere
length of mMSCs growing under hypoxia and under nor-
moxia was measured for 3 weeks in culture (Figure 4). At
the beginning of the culture period, the telomere length in
mMSCs was slightly longer (123AU to 155AU) than in the
reference cells (new-born skin fibroblasts, set as 100AU),
but this declined during in vitro expansion. Within 24 days,
telomere length had decreased to 18 ± 7AU (normoxia) or
5 ± 5AU (hypoxia), equivalent to a half-life time of about
7.8 days. Exponential fitting of the time course of telomere
shortening did not yield significant differences in the kinetic
parameter between the hypoxic and the normoxic curve.
3.6. Long-Term In Vitro Proliferative Potential of mMSCs Is
Not Affected by Oxygen Conditions in the Absence of p53.
We found evidence of higher levels of senescence and DNA
strand breaks to be present in mMSCs when kept under
normoxia (21% O
2
). The transcription factor p53 regulates
a variety of target genes affecting several cellular pathways,
all involved in establishment of both senescence and DNA
damage response [25, 26]. More prominent stabilization of
p53 after irradiation was observed as a feature of mMSCs
incubated under normoxia than under hypoxia (Supple-
mentary Figure 3). Using MSCs from p53−/− mice, we
found that in vitro proliferation was unaffected by normal
oxygen concentration (Figure 5(a)). The plating efficiency as
a measure of clonogenic potential of these cells was higher
(28% ± 3%) than in the p53wt/wt cells (2% ± 0.6%) and it
was unaffected by the oxygen concentration (Supplementary
Figure 4 and Figure 5(b)).
3.7. Senescence and 𝛾H2AX Repair Foci Formation Are
Reduced in p53−/− Irrespective of Oxygen Levels. In p53-
deficient mMSCs, the spontaneous frequency of senes-
cence was significantly lower as compared to senescence in
p53wt/wt mMSCs, both under hypoxic growth conditions
(9.8% ± 1.5%), as well as in cells kept in normoxia (7.2% ±
1.8%) (Figure 6(a)). The difference of 2.6% (±3.3%) in the
senescence level between hypoxic and normoxic p53−/−
mMSCs remained unaltered after additional 𝛾-irradiation
(0.2Gy, 0.5 Gy and 4Gy), despite the frequency itself being
increased in a similar fashion as in normoxic p53wt/wt cells
(Figure 2(b)).
The number of radiation-induced DNA double strand
breaks (𝛾H2AX repair foci) under both hypoxic and nor-
moxic conditions (0.4 foci per cell were similar to the results
of p53wt/wt cells under hypoxia) is in line with our previous
observations (Figure 6(b)). Basal levels of 𝛾H2AX repair foci
after sham-irradiation (0Gy)were in the range of hypoxic p53
wild-type mMSCs, with mean values of 0.4 ± 0.08 and 0.5 ±
0.08 foci per nucleus in hypoxia and normoxic conditions,
respectively. After 𝛾-irradiation of 4Gy, the number of
𝛾H2AX repair foci after 90min increased significantly to 1.1
(normoxia) or 1.4 (hypoxia) foci per nucleus, representing
highly effective ongoing DNA repair compared to p53 wild-
typemMSCs irrespective of oxygen conditions applied.These
results show that p53 is a key factor in modulating both
senescence induction andDNA repair efficiencies inmMSCs.
4. Discussion
Mesenchymal stem cells in their normal physiological state
reside in a stem cell niche with low-oxygen pressure [17, 18].
Since they have a lower metabolic rate than the committed
precursor cells and differentiated cells derived from them
[27, 28], they are less dependent on high oxygen supply.
Considering that their main function is the long-term regen-
eration of precursor cells of different lineages and hence the
maintenance of a stable genome, a reduction of radical oxy-
gen species (ROS) in a tissue environment with lower oxygen
pressure and low metabolic activity could be beneficial. This
protective hypoxic environment is compromised whenMSCs
are isolated and expanded ex vivo but also by exposure to any
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Figure 5: Impact of p53 status on oxygen effect of long-term in vitro culturing and colony formation capacity of mMSCs. (a) Morphology of
mMSCs p53−/− cultured in hypoxic conditions (left image) and in normoxic conditions (right image). Representative images show mMSCs
p53−/− cultured for 20 days. (b) Colony forming ability of mMSCs p53−/− after 14 days in hypoxic (grey bar) and normoxic (black bar)
cultures calculated as mean values of fibroblast colony-forming units (CFU-F) per plated cell (3 biological replicates).
kind of ionizing radiation (IR) in vivo or in vitro. IR has the
capacity to generate ROS- andOH-radicals from intracellular
water, thereby bypassing the otherwise protective hypoxic
stem cell niche [29].
We have shown that growth under ambient oxygen levels
(i.e., 21%) compromises MSC proliferation when compared
to growth under hypoxia (i.e., 2%). This is in line with
observations by others, who suggested using reduced oxygen
cell culture systems [22, 30]. In a therapy model, it has been
shown that transientmaintenance of humanMSCs in hypoxia
prior to autologous therapy increased their efficacy in the
treatment of idiopathic pulmonary fibrosis, and that this was
accompanied by enhanced survival of the grafted mMSCs
[31].
We have shown here that the impairment of MSC pro-
liferation under normoxia was associated with an increase
in cellular senescence. Senescence would not only preclude
further stem cell expansion but also would hamper the
differentiation capacity of the already existing cells [32].
Senescence can be triggered by various cellular signals: short-
ened telomeres that bring dividing cells close to the Hayflick
limit [33], accumulated DNA damage [34], or activated
oncogenes [35]. Measuring the average telomere length in
the proliferating MSCs over several weeks in culture showed
a clear reduction with time but no difference between cells
grown under normoxia or low oxygen. We can therefore
exclude that telomere shortening is involved in the oxygen
sensitivity of MSCs.
There was, however, a striking increase in the level of
DNA damage as detected by 𝛾H2AX repair foci in cells that
stopped growing after two weeks in normoxia. We tested the
assumption thatDNA lesions are causing senescence inMSCs
























































Figure 6: Impact of p53 status on senescence induction and number of DNA repair foci. (a) Graph shows percentage of p53−/− mMSCs
undergoing senescence in hypoxic and normoxic conditions after exposure to 𝛾-irradiation (sham-irradiated = 0Gy, 3 biological replicates),
radiation dose on logarithmic scale. (b) Quantification of p-𝛾H2AX foci in 50 p53−/−mMSC nuclei depicted as mean values ± standard error
of the mean (3 biological replicates).
by subjecting cells in hypoxia and in normoxia to various
doses of Cs-137 𝛾-irradiation. With 500mGy, we observed
a significant increase in the frequency of senescent cells
grown in normoxia compared to cells grown under hypoxic
conditions. A radiation dose of this range could be delivered
to long-living stem cells by 25 repeated computer tomography
exposures (20mGy each) and should warrant ex vivo expan-
sion of MSCs collected from parts of the human body that
might have been exposed to repeated radiation doses in the
past. MSCs kept at 2% low oxygen exhibit signs of senescence
only in 31% of cells as compared to 53% in normoxic cells.
MSCs grown under reduced oxygen not only exhibit a
lower percentage of senescent cells but also responded much
less severe to 𝛾-irradiation. Up to a dose of 500mGy, the
relative number of senescent cells did not increase above the
control level, and we had to expose the cells with 4000mGy
to see a slight increase in senescence to 39%. This shows
that the detrimental effects of ionizing radiation on MSCs
proliferation are dependent on a non-physiologically high
oxygen atmosphere (EPHOSS [19]) during ex vivo growth,
which should be avoided while explanting as well as ex vivo
expanding of MSCs in particular from patients who might
have accumulated radiation-induced DNA damage in their
MSCs prior to an autologous therapy.
In vitro expanded hMSCs treated with ROS-inducing
chemical were found to exhibit an increased number of
53BP1-stained DNA repair foci, which in part could be
rescued by adding an antioxidant [36]. This shows that the
potential for induction of damage to the genomic DNA is
greater under high oxygen levels but does not exclude other
cellular targets (such as membranes or mitochondria) as
potential mediators of the effect.
The suggestion that DNA damage induced by non-
physiologically high oxygen and/or ionizing radiation can
act synergistically in causing premature cell senescence was
strengthened by the observation that MSCs with a homozy-
gous deletion in the p53 gene (i.e. the main signal transducer
for DNA damage response) grow considerably faster than
wild-type MSCs, both under normoxia and under hypoxia.
It is interesting to note that p53−/− mice do not show any
defect in the growth or regeneration of mesenchymal tissue,
rather an increased rate of tumors derived from cells of all
germ layers [37]. This suggests that p53 is dispensable for the
normal physiological function of MSCs. On the other hand,
it was shown that hMSCs expanded for a prolonged time in
in vitro hypoxia exhibit a change in their gene expression
profile, in particular for three transcription factors (c-MYC,
p53, and HIF1) that are frequently amplified, mutated, or
overexpressed in cancer [38] and that this led to a higher
transformation frequency after exposure of the cells toNiSO
4
.
One suggestion from this observation was that genomic
instability could be the result of forced proliferation and
hypoxia. Our data show, however, that MSCs under hypoxia
rather exhibit less spontaneous DNA strand breaks, therefore
excluding the possibility that hypoxia per se is genotoxic.
But it might be that premature senescence triggered by non-
physiologically high oxygen indeed prevents amalignant pro-
gression, albeit on the expense of reduced cell proliferation.
5. Conclusions
We have shown that impaired growth of MSCs under a
normoxic atmosphere ex vivo is associated with accumulated
DNA damage but not with additional telomere attrition.This
10 Stem Cells International
impaired growth causes not only a reduced cell number but
also, due to increased senescence, a loss of stem cell potency.
The observation that radiation-induced DNA damage and
high oxygen atmosphere seem to act synergistically advices
caution not to explant MSCs from regions of the body that
might have been radiation-exposed earlier in life, as for
diagnostic X-ray imaging or therapeutic purposes. It might
even be an option to store MSCs from tissues easily available
early in life, thus sparing them fromexcess radiation exposure
and having them available as a repository for autologous
organ regeneration later in life.
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